![J&J Vaccine Gets Nod For Reapproval After Review Of ‘Extremely Rare’ Blood Clots](https://img.huffingtonpost.com/asset/6082df4e260000c832b41630.jpeg?cache=kegqk22z6q&ops=1778_1000)
J&J Vaccine Gets Nod For Reapproval After Review Of ‘Extremely Rare’ Blood Clots
HuffPost
A rare side effect, seen by 1.9 people per million doses given, forced the CDC and FDA to pause distribution of the COVID-19 vaccine last week.
After a brief pause, a panel of Centers for Disease Control and Prevention advisers has voted to recommend reapproval for the single-shot Johnson & Johnson coronavirus vaccine ― albeit with a new warning about extremely rare blood clots. Federal officials are expected to officially reapprove the vaccine in the near future. The U.S. Food and Drug Administration and the CDC halted distribution of the vaccine last Tuesday “out of an abundance of caution” after some recipients developed a rare disorder involving blood clots and low blood platelets within two weeks of their vaccination.More Related News